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Abstract: The Mediterranean diet (MD) is recognized as one of the healthiest dietary patterns and has
benefits such as improving glycaemic control among patients with type 2 diabetes (T2DM). Our aim is
to assess the effectiveness of a multifactorial intervention to improve adherence to the MD, diet quality
and biomedical parameters. The EMID study is a randomized and controlled clinical trial with two
parallel groups and a 12-month follow-up period. The study included 204 subjects between 25–70 years
with T2DM. The participants were randomized into intervention group (IG) and control group (CG).
Both groups received brief advice about healthy eating and physical activity. The IG participants
additionally took part in a food workshop, five walks and received a smartphone application for three
months. The population studied had a mean age of 60.6 years. At the 3-month follow-up visit, there
were improvements in adherence to the MD and diet quality of 2.2 and 2.5 points, compared to the
baseline visit, respectively, in favour of the IG. This tendency of the improvement was maintained,
in favour of the IG, at the 12-month follow-up visit. In conclusion, the multifactorial intervention
performed could improve adherence to the MD and diet quality among patients with T2DM.
Keywords: Mediterranean diet; type 2 diabetes; health education; information and
communication technologies
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1. Introduction
The term “Mediterranean diet” refers to the eating habits traditionally followed by peoples
living around the Mediterranean Sea [1]. It is characterized by the high consumption of vegetables,
monounsaturated fatty acids (mainly from olive oil), fruits, whole grains, legumes and fish; moderate
consumption of dairy products, fish and red wine; and low consumption of red or processed meats [2,3].
The Mediterranean diet is recognized as one of the healthiest dietary patterns [4]. It is associated
with significant improvements in glycaemic control and weight loss [5], as well as with the prevention
of cardiovascular diseases, cancer and diabetes mellitus type 2 (T2DM) [6–8] due to its antioxidant and
anti-inflammatory effects. It has been suggested that the benefits of this pattern T2DM are the result of
its effect on insulin sensitivity and resistance, satiety factors and hormone secretion [9], in addition to
the high fibre content and low glycaemic index of its components.
Numerous studies have carried out interventions with the aim of increasing adherence to the
Mediterranean diet [10,11]. The systematic review by Maderuelo-Fernández et al. [12] showed that
the most effective interventions were carried out by trained personnel focused on a population
with a disease. More specifically, the interventions carried out by Cubillos et al. [13] and
Gomez-Huelgas et al. [14] achieved a two-point increase in adherence to the Mediterranean diet
among patients with T2DM. The review by Álvarez-Bueno et al. [15] also showed that multifactorial
interventions were the most effective because improvement in lifestyle habits, such as a healthy diet
and increased physical activity, are cornerstones in the treatment of T2DM [16].
Kim et al. [17] showed an inverse correlation between dietary improvement and glycaemic control
markers. Therefore, diet quality should also be taken into account when assessing the diets of patients
with T2DM. Murray et al. [18] concluded that the quality of the diet was lower among this population
than the healthy population, even though no differences in the individual intake of macronutrients
was detected.
With the advances in new technologies, consideration is needed to determinate how they can best
be incorporated as new tools into multifactorial interventions. Mullet et al. [19] concluded that 70% of
mHealth interventions were effective in improving diet quality. More specifically, subgroups of the
diabetic population that used cell phones obtained greater benefit [20]. Although studies have used
mHealth to help improve diet in the diabetic population [21], we have not found interventions that
included a smartphone application with the aim of increasing adherence to the Mediterranean diet in
this population.
The objective of this study is thus to assess the effectiveness of a multifactorial intervention
involving a food workshop and a smartphone application in improving adherence to the Mediterranean
diet and diet quality among patients with T2DM.
2. Materials and Methods
2.1. Study Design
The EMID study [22] (Effectiveness of a multifactorial intervention based on an application for
smartphones, a nutritional workshop and heart-healthy walks, in patients with T2DM in primary care)
is a randomized, controlled clinical trial with two parallel groups and a follow-up period of 12 months.
The study was carried out in the field of primary health care, in the Alamedilla Research Unit, which
belongs to the Research Network on Preventive Activities and Health Promotion (redIAPP) and the
Biomedical Research Unit of Salamanca (IBSAL).
2.2. Participants
One of the objectives was to obtain a sample that is the most representative of the studied
population. Therefore, the subjects were selected by stratified random sampling from among the
patients with T2DM who sought medical attention at the Alamedilla Health Centre. The subjects were
divided according to their age into two groups (25–50 and 51–70 years).
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The inclusion criteria were age between 25 and 70 years, T2DM, agreement to participate in
the study and signing an informed consent document after receiving information about the study.
As diagnostic criteria for T2DM, we followed the latest recommendations of the American Diabetes
Association: fasting plasma glucose above 126 mg/dL or two-hour plasma glucose above 200 mg/dL
during an oral glucose tolerance test (using a glucose load containing the equivalent of 75 g anhydrous
glucose dissolved in water) or glycosylated haemoglobin over 6.5%. In all cases, these tests were
repeated to confirm the results in the absence of unequivocal hyperglycaemia. Additionally, patients
were also considered as having T2DM if they had the classic symptoms of hyperglycaemia or
hyperglycaemic crisis (i.e., random plasma glucose above 200 mg/dL) [23].
The exclusion criteria were a history of cardiovascular events, musculoskeletal pathology that
prevents walking and clinically demonstrable neurological or neuropsychological disease, which
would prevent the subject from visiting the health centre.
2.3. Common Advice
All participants received standardized counselling for 10 min about healthy eating and physical
activity. The food section lasted five minutes and focused on the use of the plate method and
recommendations to help comply with the Mediterranean diet. Five minutes were also used to
give advice to help comply with current international recommendations regarding physical activity.
A brochure was given to the participants for support in both areas.
2.4. Randomization and Masking
Participants were randomized at 1:1 into the control group (CG) (102) or the intervention group
(IG) (102). The randomization was performed after obtaining informed consent and was not revealed
prior to group assignment. The allocation sequence was generated by an independent researcher using
the software Epidat 4.0 (Consellería de Sanidade, Santiago de Compostela, Spain) (Figure 1).
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2.5. Intervention 
A multifactorial intervention was carried out with groups of 10 participants consisting of a food 
workshop, a smartphone application and heart-healthy walks. To impart this multifactorial 
intervention, three nurses from the health centre were instructed in two one-hour training classes on 
how to carry out the interventions in a standardized manner (what points should be treated, in what 
order and for how long). 
2.5.1. Food Workshop 
The food workshop was a theoretical and practical workshop that lasted 90 minutes and focused 
on improving adherence to the Mediterranean diet. The workshop covered the following topics: 
benefits of a healthy diet, food groups, components of the Mediterranean diet, recommended 
culinary techniques, the use of the plate method and the importance of food labelling for patients 
with diabetes. Adherence to the food workshop was assessed by the attendance or lack thereof. 
2.5.2. Smartphone Application (EVIDENT II) 
A one-hour group workshop was held to instruct the participants in the use of the EVIDENT II 
application (intellectual property registry number SA-81-14) (CGB, Salamanca, Spain), which was 
installed on a mobile phone that was provided for them to use for three months. This application was 
designed by software engineers in collaboration with dieticians and physical activity experts with the 
aim of promoting adherence to the Mediterranean diet and it has already been used in previous 
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Due to the nature of the intervention, the participants could not be blinded. However, the
researcher who carried out the intervention in the study group was different from the person
responsible for the assessment and standardized counselling. In addition, the person responsible for
the statistical analysis remained blinded throughout the study. During the follow-up visits, patients
were told that they should not use other health technologies. Moreover, the application was not made
available online until the end of the study so that the control group could not access it.
2.5. Intervention
A multifactorial intervention was carried out with groups of 10 participants consisting of a
food workshop, a smartphone application and heart-healthy walks. To impart this multifactorial
intervention, three nurses from the health centre were instructed in two one-hour training classes on
how to carry out the interventions in a standardized manner (what points should be treated, in what
order and for how long).
2.5.1. Food Workshop
The food workshop was a theoretical and practical workshop that lasted 90 min= and focused
on improving adherence to the Mediterranean diet. The workshop covered the following topics:
benefits of a healthy diet, food groups, components of the Mediterranean diet, recommended culinary
techniques, the use of the plate method and the importance of food labelling for patients with diabetes.
Adherence to the food workshop was assessed by the attendance or lack thereof.
2.5.2. Smartphone Application (EVIDENT II)
A one-hour group workshop was held to instruct the participants in the use of the EVIDENT
II application (intellectual property registry number SA-81-14) (CGB, Salamanca, Spain), which was
installed on a mobile phone that was provided for them to use for three months. This application was
designed by software engineers in collaboration with dieticians and physical activity experts with
the aim of promoting adherence to the Mediterranean diet and it has already been used in previous
studies [24,25]. The application was configured with the data of each participant (age, sex, weight,
height and stride distance). After entering food intake and daily exercise data, it would provide
detailed information on nutritional deviations in terms of both diet composition and the number of
calories, with the aim of encouraging a change of habits. The cell phone was returned after three
months, at follow-up visit for both groups. Subsequently, the stored information was downloaded.
Adherence to the smartphone app was assessed by the number of days of recordings in the device.
After this three-month intervention period, the subjects did not have access to the EVIDENT II app
because it was not freely available online.
2.5.3. Heart-Healthy Walks
Once a week for 5 weeks, the subjects performed 10 min of warm-up, walked 4 km on flat terrain
and performed 10 min of stretching and relaxation. In order to make the walks qualify as aerobic
exercise (50–70% maximum heart rate) [26], participants were divided into two groups according to
on intensity. The approximate speed was 6 km/hour for the group walking at moderate intensity (5
metabolic equivalents (METs)) and 3–4 km/hour for the group walking at low intensity (2.5 METs).
Adherence to heart-healthy walks was evaluated by the number of days, planned in the intervention
that the subjects attended to perform them.
2.6. Outcome Measures and Follow-Up
To assess the effect of the multifactorial intervention, follow-up was carried out at baseline, three
months and 12 months after the initial intervention. As the main endpoint, we considered the change
in total score of the Mediterranean Diet Adherence Screener (MEDAS) questionnaire [27], while the
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total score of the Diet Quality Index (DQI) questionnaire [28] and the clinical variables were treated as
secondary endpoints.
2.6.1. Adherence to the Mediterranean Diet
The main result variable was measured using the validated fourteen-item MEDAS questionnaire,
developed by the PREDIMED group, which includes 12 questions about the frequency of food
consumption and two questions about typical eating habits for the Spanish population [27]. Each
question was scored with zero or one point. One point was given for using olive oil as the main fat
for cooking, preferring white meat to red meat and daily consumption of four or more tablespoons
(one tablespoon = 13.5 g) of olive oil (including oil used for frying, dressing salads, etc.), two or more
servings of vegetables, three or more pieces of fruit, less than one serving of red meat or sausage, less
than one serving of animal fat and less than one cup (one cup = 100 mL) of carbonated or sugary
drinks. One point was also given for weekly intake of seven or more glasses of wine, three or more
servings of legumes, three or more servings of fish, two shop-bought pastries or fewer, three or more
servings of nuts and two or more helpings of sofrito (a traditional sauce made with tomato, garlic,
onion or leeks and sautéed with olive oil). The final score range was 0 to 14 points, with 9 or more
points indicating suitable adherence to the Mediterranean diet [27].
2.6.2. Diet Quality Index
The diet was assessed with the DQI [28]. This questionnaire covers 18 food groups, labelled one,
two or three depending on whether their consumption is beneficial (eating more results in a higher
score) or harmful to health (eating more produces a lower score). Food groups are classified into three
categories according to the recommended frequency of use. The first category includes eight foods and
their response types are “less than once a day,” “once a day” or “more than once a day.” The second
category has seven foods and their responses are “less than four times a week,” “four to six times a
week” or “at least once a day.” Finally, in the third category, there are three foods, which are classified
as “less than twice a week,” “two to three times a week” or “four or more times a week” [28]. Scores
range from 18 to 54 points, with a higher score representing higher diet quality and 40 or more points
indicate a suitable quality of diet.
2.6.3. Clinically Relevant Measures
Other variables were measured, including drug use, blood pressure, postprandial glucose,
weight, height, waist circumference (WC) and biochemical parameters (total serum cholesterol,
LDL-cholesterol, HDL-cholesterol). Body mass index (BMI) was calculated by dividing the weight
(kg) by the square of the height (m2). The body shape index (ABSI) was estimated with the following
equation: ABSI = WC (m)/(BMI2/3 × height (m)1/2). A detailed description of the way in which
these variables were measured was published with the study protocol [22].
2.7. Sample Size Calculation
The sample size was estimated a priori, considering the increase in the total score of the MEDAS
questionnaire as the main endpoint. Assuming alpha = 0.05 and beta = 0.20 with an SD of 2 points, we
needed 140 participants (70 per group) in order to detect an increase of 1 point in the IG’s MEDAS
score compared to the CG while allowing for an expected drop-out rate of 10%. In addition, for an
SD of 2.4 points in the DQI score, we needed 202 participants (101 per group) in order to detect an
increase of 1 point in the IG’s DQI score compared to the CG with the same dropout rate. Therefore,
we considered 204 subjects to be a sufficient number for detecting clinically relevant differences in the
main variables of the study.
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2.8. Ethical Considerations
The study was approved by the Clinical Research Ethics Committee of the Health Area of
Salamanca on 28 November 2016. All procedures were performed in accordance with the ethical
standards of the institutional research committee and with the 2013 Declaration of Helsinki [29].
All patients signed written informed consent documents prior to participation in the study. The trial
was registered at ClinicalTrials.gov with identifier NCT02991079.
2.9. Statistical Analysis
Continuous variables are presented as means ± standard deviations and qualitative variables are
presented using a frequency distribution. To compare categorical variables at baseline between IG and
CG the chi-squared test or Fisher exact test was carried out as appropriate and quantitative variables
were compared using the student’s t-test. The ANCOVA test was used to compare the changes between
the IG and the CG, adjusting for the basal measurement of each variable. Repeated-measures analysis
of variance was used to analyse group interaction effects on changes in the Mediterranean diet and
DQI scores using the General linear Model (GLM) procedure. For the bilateral contrast of hypotheses,
an alpha risk of 0.05 was set as a limit of statistical significance. The data were analysed using the
statistical software SPSS for Windows version 25.0. (IBM Corp, Armonk, NY, USA).
3. Results
3.1. Sample Selection
Among the 1291 subjects with T2DM between 25–70 years old seen at the La Alamedilla Health
Centre, 473 were selected by stratified random sampling. Subsequently, 103 were excluded because
they did not meet the inclusion criteria, 137 did not want to be included in the study and 29 were
excluded for other reasons. Finally, 204 subjects were included in the study. There were 19 subjects
who were lost in follow up (11 in the CG and 8 in the IG, p > 0.05). The reasons for dropping out are
detailed in the flowchart in Figure 1.
3.2. Demographic and Clinical Characteristics of the Included Subjects
Table 1 presents the baseline characteristics of the participants. The study population had an
average age of 60.6 ± 8.1 years and 45.6% (N = 93) were women. At the baseline visit, there were no
significant differences between the groups in terms of demographic characteristics.
Table 1. Baseline characteristics of patients.
Control Group (102) Intervention Group (102) p-Value
Age (years), mean (SD) 60.4 (8.4) 60.8 (7.8) 0.84
Gender (female), n (%) 41 (40.2) 52 (51.1) 0.08
Diabetes duration (years), mean (SD) 6.7 (4.7) 6.4 (4.6) 0.62
BMI (kg/m2), mean (SD) 30.3 (5.6) 29.5 (4.2) 0.27
Obesity, n (%) 48 (47.1) 43 (42.2) 0.48
Work situation, n (%)
Works outside home 41 (40.2) 29 (28.4)
0.91
Homemaker 18 (17.6) 24 (23.5)
Retired 34 (33.3) 44 (43.1)
Unemployed 7 (6.8) 5 (4.9)
Educational level, n (%)
University studies 17 (16.7) 17 (16.7)
0.94Middle or high school 33 (32.4) 37 (36.3)
Elementary school 52 (51.0) 48 (47.1)
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Table 1. Cont.
Control Group (102) Intervention Group (102) p-Value
Smoking, n (%)
Non-smoker 37 (36.3) 39 (38.2)
0.13Smoker 26 (25.5) 10 (9.8)
Former smoker 39 (38.2) 53 (51.9)
Medication use, n (%)
Antihypertensive drugs 55 (53.9) 58 (56.9) 0.24
Lipid-lowering drugs 59 (57.8) 58 (52.0) 0.39
Antidiabetic drugs 89 (87.3) 93.0 (91.2) 0.37
Insulins 18 (17.6) 12 (11.8) 0.24
Metformin 81 (79.4) 82 (80.4) 0.86
Sulphonylureas 8 (7.8) 6 (5.9) 0.58
Thiazolidinediones 3 (2.9) 3 (2.9) 1.0
SGLT2 Inhibitors 1 (1.0) 2 (2.0) 0.56
Meglitinides 2 (2.0) 4 (3.9) 0.41
DPP-4 inhibitors 38 (37.3) 37 (36.3) 0.89
GLP-1 receptor agonists 1 (1.0) 4 (3.9) 0.18
Variables are given as means ± standard deviations, numbers and %. p value differences between control group
and intervention group. Abbreviations: IQR: Interquartile Range; SD: Standard Deviation; BMI: Body Mass Index;
SGLT2: Sodium-glucose co-transporter-2; DPP-4: Dipeptidyl peptidase 4; GLP-1: Glucagon-like peptide-1.
3.3. Adherence to the Intervention
The adherence to the food workshop was 82.3% (84/102 subjects). The majority of the subjects
(63.7%, 65/102 subjects) carried out between 4 to 5 heart-healthy walks. The average use of the
application was 35 days and most of the subjects (69.6%, 71/102) used it for 31 to 60 days.
3.4. Effect of the Intervention
In the CG, the scores of the adherence to the Mediterranean diet showed few variations throughout
the study (6.9, 7.1 and 7.0 points, respectively) and the same thing happened in the quality of the
diet (40.2, 40.8 and 40.4 points, respectively). However, in the IG, an increase in adherence to the
Mediterranean diet was observed in the follow-up visits with respect to the baseline visit (7.2, 9.4 and
8.5 points, respectively), as well as in the quality of the diet (39.8, 42.9 and 41.8 points, respectively), as
shown in Table 2.
Table 3 shows the intergroup modifications that occurred in the follow-up visits with respect
to the baseline visit. At the 3-month follow-up visit, compared to the baseline visit, there was an
improvement in the adherence to the Mediterranean diet and the quality of the diet of 2.2 points
(1.8–2.5) and 2.5 points (1.9–3.0), respectively, in favour of the IG. In the same way, these improvements
were maintained in the follow-up visit at 12 months, with an increase of 1.3 points (0.8–1.8) in the
adherence to the Mediterranean diet and 1.7 points (1.0–2.4) in the quality of the diet, with respect
to the baseline visit (p < 0.01 for all). At the 3-month follow-up visit, 82.7% of the IG participants
increased their MEDAS questionnaire score by at least 1 point, while in the CG this value was 31.3%;
at the 12-month follow-up visit, 61.9% of the IG participants and 38.5% of the CG participants reached
this increase.
Taking into account the terms of the MEDAS questionnaire, there was an improvement in the
follow-up visit at 3 months, in favour of the IG, in the daily use of at least 4 tablespoons of olive oil, 2
servings or more vegetables and at least 3 servings of fruits, as well as in the weekly consumption of at
least 3 servings of fish or seafood, 2 or fewer servings of commercial baked goods, at least 3 servings of
nuts, 2 or more servings of sofrito sauce and finally and a greater consumption of white meats than
red meats. The improvements were maintained at 12 months of follow-up, in the consumption of olive
oil, fish or seafood, nuts, white meats and sofrito sauce. (p < 0.05 for all; Table 3).
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Table 2. Adherence to the Mediterranean diet and diet quality throughout the study.
Baseline 3-Month Follow Up 12-Month Follow Up
Control Group Intervention Group Control Group Intervention Group Control Group Intervention Group
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Total score (points)
Mediterranean Diet Adherence Screener 6.9 (1.7) 7.2 (1.9) 7.1 (1.7) 9.4 (1.7) 7.0 (1.9) 8.5 (1.9)
Diet Quality Index 40.2 (2.6) 39.8 (2.6) 40.8 (2.7) 42.9 (2.5) 40.4 (2.7) 41.8 (2.8)
Mediterranean diet criteria (%)
Use olive oil as main culinary fat 89.0 (31.2) 96.0 (19.5) 92.0 (27.8) 99.0 (10.1) 88.0 (32.8) 98.0 (14.3)
Olive oil ≥ 4 tablespoons 15.0 (35.6) 17.0 (37.5) 17.0 (37.5) 43.0 (49.7) 20.0 (40.1) 48.0 (50.2)
Vegetables ≥ 2 servings/day 20.0 (39.9) 24.0 (42.6) 23.0 (42.3) 52.0 (50.2) 22.0 (41.6) 34.0 (47.6)
Fruits ≥ 3 servings/day 51.0 (50.2) 54.0 (50.1) 59.0 (49.4) 76.0 (43.2) 57.0 (49.8) 64.0 (48.3)
Red or processed meats < 1 serving/day 97.0 (17.0) 91.0 (28.5) 96.0 (20.1) 93.0 (25.9) 91.0 (28.5) 92.0 (27.7)
Butter, cream or margarine <1 serving/day 92.0 (27.0) 86.0 (34.6) 93.0 (26.1) 93.0 (26.7) 95.0 (22.9) 91.5 (26.4)
Sugar-sweetened beverage < 1 cup/day 76.0 (42.6) 88.0 (32.4) 87.0 (33.2) 97.0 (17.3) 86.0 (35.2) 93.0 (25.1)
Red wine ≥ 7 servings/week 15.0 (35.6) 19.0 (39.1) 12.0 (33.2) 20.0 (40.5) 14.0 (35.2) 15.0 (36.3)
Legumes ≥ 3 servings/week 19.0 (39.1) 21.0 (40.6) 26.0 (44.1) 34.0 (47.5) 25.0 (43.7) 26.0 (44.0)
Fish or seafood ≥ 3 servings/week 42.0 (49.6) 51.0 (50.2) 47.0 (50.2) 66.0 (47.5) 44.0 (49.9) 61.0 (49.1)
Commercial bakery ≤ 2 servings/week 47.0 (50.2) 32.0 (47.0) 38.0 (48.7) 46.0 (50.1) 31.0 (46.4) 29.0 (45.5)
Nuts ≥ 3 servings/week 24.0 (42.6) 27.0 (44.8) 28.0 (45.2) 51.0 (50.2) 20.0 (40.1) 42.0 (49.7)
White meats more than red meats 58.0 (49.6) 71.0 (45.8) 56.0 (49.9) 89.0 (31.7) 66.0 (47.7) 87.0 (34.2)
Use of sofrito sauce ≥ 2 servings/week 49.0 (50.2) 48.0 (50.0) 39.0 (48.9) 83.0 (38.1) 45.0 (50.0) 66.0 (47.6)
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Table 3. Intergroup modifications of the diet parameters in the follow-up visits compared to the baseline visit.
3 Months vs. Baseline 12 Months vs. Baseline
Mean (95% CI) p Mean (95% CI) p
Total score (points)
Mediterranean Diet Adherence Screener 2.2 (1.8–2.5) <0.001 1.3 (0.8–1.8) <0.001
Diet Quality Index 2.5 (1.9–3.0) <0.001 1.7 (1.0–2.4) <0.001
Mediterranean diet criteria (%)
Use olive oil as main culinary fat 4.3 (−5.0–9.1) 0.080 0.8 (1.4–14.5) 0.017
Olive oil ≥ 4 tablespoons 25.9 (14.3–37.5) <0.001 28.4 (15.5–41.4) <0.001
Vegetables ≥ 2 servings/day 26.8 (16.1–37.5) <0.001 10.8 (1.6–23.2) 0.087
Fruits ≥ 3 servings/day 15.0 (4.8–25.2) 0.004 4.9 (−7.6–17.3) 0.441
Red or processed meats < 1 serving/day 3.4 (−10.0–3.2) 0.313 1.1 (−7.1–9.2) 0.793
Butter, cream or margarine < 1 serving/day 3.7 (−2.1–9.6) 0.211 3.2 (−1.7–8.9) 0.325
Sugar-sweetened beverage < 1 cup/day 5.4 (−1.2–11.9) 0.109 2.2 (−6.2–10.5) 0.608
Red wine ≥ 7 servings/week 5.3 (−2.3–12.8) 0.169 −0.3 (−7.6–7.1) 0.945
Legumes ≥ 3 servings/week 6.6 (−5.7–18.8) 0.292 0.6 (−11.4–12.5) 0.926
Fish or seafood ≥ 3 servings/week 12.8 (2.3–23.4) 0.018 12.9 (0.2–25.6) 0.046
Commercial bakery ≤ 2 servings/week 18.1 (6.1–30.0) 0.003 3.9 (−8.5–16.2) 0.537
Nuts ≥ 3 servings/week 22.1 (10.1–34.1) <0.001 21.9 (9.9–33.9) <0.001
White meats more than red meats 27.3 (17.3–37.3) <0.001 16.1 (5.4–26.9) 0.004
Use of sofrito sauce ≥ 2 servings/week 44.1 (31.8–56.4) <0.001 21.0 (7.0–35.0) 0.004
p value differences between intervention group and control group. Significant difference: p < 0.05. An analysis of
covariance adjusting for baseline was used to examine the significance of differences.
Figure 2 shows the evolution of the percentage of compliance of the Mediterranean diet and
the DQI index in the IG and CG. At the follow-up visits at 3 and 12 months, the number of subjects
with suitable adherence to the Mediterranean diet (MEDAS score ≥ 9 points) in the IG increased
significantly compared to the CG. In the same way, there was an increase in the IG of the number of
subjects with a suitable quality of diet (DQI score ≥ 40 points), with respect to the CG. This difference
was significant in the follow-up visit at 3 months. (p < 0.05 for all).Nutrients 2019, 11, x FOR PEER REVIEW 2 of 16 
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In addition, a significant interaction effect (p < 0.001) was found between the IG and the changes
in adherence to the Mediterranean diet and diet quality throughout the 12 months of follow-up.
(Figure 3).
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Figure 3. Changes in the MEDAS score and the DQI score tasks in response to the multifactorial
intervention. Repeated-measures ANOVA was been performed with adjustment for the baseline visit.
MEDAS: Mediterranean Diet Screener; DQI: Diet Quality Index.
Finally, without significant changes in the consumption of antidiabetic drugs, the following
improvements were observed at the 3-month follow-up visit compared to the baseline visit: a
postprandial gluc se improvement of −9.4 mg/dL (−18.0–−0.8), a waist circumference improvement
of −2.5 c (−3.3–−1.6) and a BMI improvement of −0.3 kg/m2 (−0.6–0.0) in favour of the IG (p < 0.05
f r all; Tables 4 and 5). The i provements of some of the clinical parameters wer maintained at
the follow-up visit at 12 months compared to baseline, such as a postprandial glucose im rovement
of −6.6 mg/dL (−14.9–1.7), waist circumference improvement of −0.9 cm (−3.1–1.2) nd systolic
Nutrients 2019, 11, 162 11 of 15
blood pressure improvement of −1.5 mmHg (−8.7–5.7) However, the results did not reach statistical
significance (p > 0.05).
Table 4. Clinical variables throughout the study.
Baseline 3-Month Follow Up 12-Month Follow Up
Control
Group
Intervention
Group
Control
Group
Intervention
Group
Control
Group
Intervention
Group
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Glycated
haemoglobin (%) 6.8 (1.2) 6.9 (1.2) 6.8 (1.1) 6.8 (1.0) 7.0 (1.3) 6.9 (1.1)
Postprandial glucose
(mg/dL) 147.6 (35.5) 149.2 (39.0) 148.9 (37.8) 140.0 (31.7) 148.3 (34.1) 143.2 (29.0)
Atherogenic index 3.8 (1.1) 3.5 (1.0) 3.7 (1.1) 3.4 (1.0) 3.6 (1.1) 3.4 (1.1)
Total serum
cholesterol (mg/dL) 176.4 (31.7) 178.8 (30.3) 173.1 (29.0) 173.7 (30.6) 173.0 (32.5) 174.8 (34.0)
LDL-cholesterol
(mg/dL) 100.4 (28.6) 101.8 (30.0) 97.9 (24.9) 97.2 (27.9) 94.9 (25.3) 95.6 (31.6)
HDL-cholesterol
(mg/dL) 50.3 (14.8) 54.4 (14.1) 49.8 (13.6) 54.0 (14.6) 51.4 (13.5) 54.1 (14.8)
Waist circumference
(cm) 104.9 (13.1) 102.2 (11.5) 105.5 (13.0) 100.4 (11.0) 104.2 (16.0) 101.2 (11.8)
Systolic blood
pressure (mmHg) 135.0 (33.2) 133.2 (15.9) 131.2 (16.4) 127.1 (15.9) 130.3 (16.4) 126.2 (15.8)
Diastolic blood
pressure (mmHg) 80.5 (9.6) 80.8 (9.0) 79.7 (9.6) 78.8 (9.5) 80.6 (8.8) 79.4 (8.5)
ABSI × 100 8.5 (0.5) 8.5 (0.4) 8.5 (0.6) 8.3 (0.4) 8.5 (0.7) 8.4 (0.4)
Abbreviations: LDL: Low density lipoprotein; HDL: High density lipoprotein; ABSI: A Body Shape Index.
Table 5. Intergroup modifications of the clinical parameters in the follow-up visits compared to the
baseline visit.
3 Months vs. Baseline 12 Months vs. Baseline
Mean (95% CI) p Mean (95% CI) p
Glycated haemoglobin (%) −0.1 (−0.3–0.0) 0.145 −0.1 (−0.4–0.1) 0.241
Postprandial glucose (mg/dL) −9.4 (−18.0–−0.8) 0.031 −6.6 (−14.9–1.7) 0.118
Atherogenic index −0.1 (−0.3–0.1) 0.324 0.0 (−0.2–0.2) 0.998
Total serum cholesterol (mg/dL) −1.8 (−8.1–4.5) 0.567 −0.9 (−8.5–6.8) 0.823
LDL-cholesterol (mg/dL) −2.6 (−8.3–3.2) 0.380 −0.1 (−6.5–6.3) 0.973
HDL-cholesterol (mg/dL) 0.8 (−1.5–3.1) 0.501 −0.1 (−2.4–2.2) 0.927
Waist circumference (cm) −2.5 (−3.3–−1.6) <0.001 −0.9 (−3.1–1.2) 0.390
Systolic blood pressure (mmHg) −3.1 (−7.1–0.8) 0.120 −1.5 (−8.7–5.7) 0.678
Diastolic blood pressure (mmHg) −1.2 (−3.3–0.9) 0.244 −1.3 (−3.5–0.8) 0.227
ABSI × 100 0.1 (−0.2–−0.1) 0.001 0.1 (−0.2–0.0) 0.198
An analysis of covariance adjusting for baseline was used to examine the significance of differences. p value
differences between intervention group and control group. Significant difference: p < 0.05. Abbreviations: CI:
Confidence Interval; LDL: Low density lipoprotein; HDL: High density lipoprotein; ABSI: A Body Shape Index.
4. Discussion
The main findings of the study were that a multifactorial intervention involving a food workshop
and a smartphone application produced improved adherence to the Mediterranean diet and diet
quality among patients with T2DM in comparison to standard treatment.
In line with our results, Zazpe et al. [30] obtained significant increases of 1.4 and 1.8 points
in Mediterranean diet adherence among patients with T2DM or cardiovascular risk factors in their
intervention groups, who were instructed to adhere to a Mediterranean diet supplemented with virgin
olive oil or mixed nuts. This is an important finding since several studies have concluded that greater
adherence to the Mediterranean diet results in an improvement in glycaemic control [31], insulin
sensitivity [32] and insulin secretion [33], which are important factors in the management of T2DM.
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Similarly, when breaking down the adherence to the Mediterranean diet by item, the results are
in line with those published by Salas-Salvado et al. [10] and Estruch et al. [34]. In addition, in this
study, the preference for white meat over red meat and the consumption of homemade sofrito at
least twice a week were modified. Several studies have explained the clinical implication that the
increases in Mediterranean diet items could have independently. Guasch-Ferré et al. [35], linked the
increase in the consumption of 10 g per day of olive oil to a 16% reduction in cardiovascular risk.
Furthermore, according to Salas-Salvado et al. [10], the consumption of nuts has a beneficial effect
on insulin resistance, blood pressure, dyslipidaemia and functions that influence the modulation
of inflammation and endothelial function. Moreover, eating fish [36] and sofrito [37] is related to
beneficial effects on cardiovascular risk factors. Kim et al. [38], linked a reduction in the consumption
of red meats to an improvement in insulin sensitivity.
These changes in dietary habits resulted in changes in the clinical variables. These changes
correspond to those achieved by other multifactorial interventions such as that of Jiang et al. [39],
who observed a decrease in postprandial glycaemia (10.7 ± 3.2 vs. 5.8 ± 2.1 mmol/L) in the IG after
12 months of follow-up, through changes in diet, exercise and a psychological approach. In the same
way, several studies [39–42] have managed to significantly improve BMI among other parameters
through a multifactorial intervention based on changes in diet and exercise in subjects with T2DM.
Finally, we think that the results obtained in this work could be pioneering, since as far as we know,
this study is the first to analyse the effects of a multifactorial intervention on diet in subjects with
T2DM based on a food workshop and a smartphone application, as well as achieving improvement in
the MEDAS and the DQI questionnaire.
This study has several limitations that should be considered when interpreting our results. First,
the exposure to the intervention was short (three months). In addition, the multifactorial nature of
the intervention means that it is not possible to know which component produced the change in the
study group. Furthermore, the main findings of the study are based on patients’ responses on nutrition
questionnaires. Finally, although the recommendation was made not to use other mobile applications,
we have no guarantee that the participants did not do so.
5. Conclusions
The results of this study suggest that the proposed multifactorial intervention involving a food
workshop and a smartphone application are moderately effective in improving adherence to the
Mediterranean diet and diet quality among patients with T2DM.
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